Display options
Cite
Pemán J, Salavert M, Cantón E, et al. Voriconazole in the management of nosocomial invasive fungal infections. Ther Clin Risk Manag. 2006;2(2):129-58doi: 10.2147/tcrm.2006.2.2.129.
Pemán, J., Salavert, M., Cantón, E., Jarque, I., Romá, E., Zaragoza, R., Viudes, A., & Gobernado, M. (2006). Voriconazole in the management of nosocomial invasive fungal infections. Therapeutics and clinical risk management, 2(2), 129-58. https://doi.org/10.2147/tcrm.2006.2.2.129
Pemán, Javier, et al. "Voriconazole in the management of nosocomial invasive fungal infections." Therapeutics and clinical risk management vol. 2,2 (2006): 129-58. doi: https://doi.org/10.2147/tcrm.2006.2.2.129
Pemán J, Salavert M, Cantón E, Jarque I, Romá E, Zaragoza R, Viudes A, Gobernado M. Voriconazole in the management of nosocomial invasive fungal infections. Ther Clin Risk Manag. 2006 Jun;2(2):129-58. doi: 10.2147/tcrm.2006.2.2.129. PMID: 18360588; PMCID: PMC1661660.
Copy Download .nbib Format: NLM
Share it on

Ther Clin Risk Manag. 2006 Jun;2(2):129-58. doi: 10.2147/tcrm.2006.2.2.129.

Voriconazole in the management of nosocomial invasive fungal infections.

Therapeutics and clinical risk management

Javier Pemán, Miguel Salavert, Emilia Cantón, Isidro Jarque, Eva Romá, Rafael Zaragoza, Angel Viudes, Miguel Gobernado

PMID: 18360588 PMCID: PMC1661660 DOI: 10.2147/tcrm.2006.2.2.129

Abstract

Voriconazole is a new triazole developed for the treatment of life-threatening fungal infections. The drug is available for both oral and intravenous administration; the oral formulation has excellent bioavailability. The side-effect profile of voriconazole presents an acceptable safety and tolerability spectrum: transient visual disturbances, liver enzyme abnormalities, and skin rashes are the most frequently reported side effects but rarely lead to discontinuation. The potential for drug-drug interactions is high, because of its extensive hepatic metabolism. Careful attention to dosage is required, and serum levels and the effects of interacting drugs should be monitored. Review of 25 470 isolates of yeasts and 3216 isolates of filamentous fungi showed voriconazole to have broad-spectrum activity against pathogenic yeasts including intrinsically fluconazole-resistant isolates such as Candida krusei, dimorphic fungi, and opportunistic moulds like Aspergillus spp, amphotericin-B-resistant Aspergillus terreus, Fusarium spp, and Scedosporium apiospermum. It displays excellent clinical efficacy in patients with fluconazole-resistant and -susceptible Candida infections, invasive bone and central nervous system aspergillosis, and various refractory fungal infections. Voriconazole has been approved by the US Food and Drug Administration and by the European Medicines Agency for the treatment of invasive aspergillosis, serious infections caused by Fusarium and S. apiospermum, fluconazole-resistant invasive Candida infections, and candidemia in nonneutropenic patients.

References

  1. Int J Antimicrob Agents. 2004 Sep;24(3):294-6 - PubMed
  2. J Antimicrob Chemother. 2004 Jan;53(1):113-4 - PubMed
  3. J Clin Microbiol. 2005 Jan;43(1):250-3 - PubMed
  4. J Antimicrob Chemother. 2005 Jun;55(6):1016-9 - PubMed
  5. J Antimicrob Chemother. 2004 Feb;53(2):283-9 - PubMed
  6. AIDS. 1998 Nov 12;12(16):2227-8 - PubMed
  7. Antimicrob Agents Chemother. 2003 Dec;47(12):3976-8 - PubMed
  8. J Antimicrob Chemother. 2000 Sep;46(3):479-83 - PubMed
  9. Rev Iberoam Micol. 2003 Jun;20(2):64-7 - PubMed
  10. J Antimicrob Chemother. 1999 Jan;43(1):149-51 - PubMed
  11. Eye (Lond). 2005 Apr;19(4):485-7 - PubMed
  12. Expert Rev Anti Infect Ther. 2004 Aug;2(4):485-97 - PubMed
  13. Antimicrob Agents Chemother. 2003 Dec;47(12):3985-8 - PubMed
  14. Eur J Clin Microbiol Infect Dis. 1998 Aug;17(8):573-5 - PubMed
  15. Haematologica. 2003 Mar;88(3):ECR05 - PubMed
  16. Antimicrob Agents Chemother. 2005 Apr;49(4):1593-6 - PubMed
  17. Bone Marrow Transplant. 2004 May;33(9):943-8 - PubMed
  18. Antimicrob Agents Chemother. 1997 Mar;41(3):696-8 - PubMed
  19. J Antimicrob Chemother. 2003 Oct;52(4):679-82 - PubMed
  20. Haematologia (Budap). 2001;31(1):73-80 - PubMed
  21. Antimicrob Agents Chemother. 1997 Jan;41(1):13-6 - PubMed
  22. Ann Hematol. 2004 Feb;83(2):133-6 - PubMed
  23. J Pediatr Hematol Oncol. 2004 Feb;26(2):117-9 - PubMed
  24. J Bone Joint Surg Am. 2005 Jan;87(1):168-71 - PubMed
  25. Clin Infect Dis. 2004 Aug 15;39(4):584-7 - PubMed
  26. Clin Infect Dis. 2004 Jul 15;39(2):192-8 - PubMed
  27. Antimicrob Agents Chemother. 2001 Feb;45(2):633-5 - PubMed
  28. Infect Control Hosp Epidemiol. 2004 Aug;25(8):628-33 - PubMed
  29. Antimicrob Agents Chemother. 2002 Apr;46(4):1032-7 - PubMed
  30. Haematologica. 2004 Nov;89(11):ECR42 - PubMed
  31. J Antimicrob Chemother. 2003 Jan;51(1):45-52 - PubMed
  32. J Laryngol Otol. 1998 Jan;112(1):92-7 - PubMed
  33. Adv Perit Dial. 2004;20:58-61 - PubMed
  34. J Clin Microbiol. 2002 Jun;40(6):2101-7 - PubMed
  35. J Infect Chemother. 2000 Jun;6(2):101-3 - PubMed
  36. J Antimicrob Chemother. 1999 Nov;44(5):697-700 - PubMed
  37. N Engl J Med. 2002 Jan 24;346(4):225-34 - PubMed
  38. Eur J Clin Microbiol Infect Dis. 2003 May;22(5):297-9 - PubMed
  39. Acta Ophthalmol Scand. 2004 Dec;82(6):762-4 - PubMed
  40. Diagn Microbiol Infect Dis. 2004 Mar;48(3):201-5 - PubMed
  41. Clin Microbiol Infect. 2003 Dec;9(12):1250-2 - PubMed
  42. J Clin Microbiol. 2003 Mar;41(3):1087-90 - PubMed
  43. J Antimicrob Chemother. 2004 Mar;53(3):526-9 - PubMed
  44. J Clin Microbiol. 2002 Oct;40(10):3841-4 - PubMed
  45. J Clin Microbiol. 2004 Feb;42(2):899-902 - PubMed
  46. Diagn Microbiol Infect Dis. 2000 Oct;38(2):101-7 - PubMed
  47. Int J Antimicrob Agents. 2005 Mar;25(3):264-7 - PubMed
  48. Clin Infect Dis. 2004 Aug 15;39(4):588-90 - PubMed
  49. J Clin Microbiol. 2005 May;43(5):2520-2 - PubMed
  50. Acta Paediatr. 2003 Aug;92(8):980-2 - PubMed
  51. Diagn Microbiol Infect Dis. 2003 Feb;45(2):131-5 - PubMed
  52. N Engl J Med. 2004 Sep 30;351(14):1445-7 - PubMed
  53. Clin Infect Dis. 2004 Oct 1;39(7):e74-7 - PubMed
  54. Arch Pediatr. 2005 Jul;12(7):1116-9 - PubMed
  55. Transplantation. 2003 Dec 15;76(11):1632-7 - PubMed
  56. N Engl J Med. 2002 Aug 8;347(6):408-15 - PubMed
  57. Clin Infect Dis. 2005 Apr 15;40(8):1141-7 - PubMed
  58. J Clin Microbiol. 2004 Feb;42(2):718-21 - PubMed
  59. Clin Infect Dis. 2005 Apr 15;40(8):1212-3 - PubMed
  60. Clin Infect Dis. 2003 Jul 15;37(2):311-3 - PubMed
  61. Med Mycol. 1998 Dec;36(6):433-6 - PubMed
  62. Ann Pharmacother. 2000 Sep;34(9):1032-43 - PubMed
  63. Clin Infect Dis. 2000 Sep;31(3):673-7 - PubMed
  64. Antimicrob Agents Chemother. 2001 Jul;45(7):2151-3 - PubMed
  65. Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):681-5 - PubMed
  66. Antimicrob Agents Chemother. 2004 Sep;48(9):3317-22 - PubMed
  67. AIDS. 2001 Nov 23;15(17):2344-5 - PubMed
  68. Clin Microbiol Infect. 2004 Mar;10 Suppl 1:107-17 - PubMed
  69. J Chemother. 2005 Aug;17(4):417-27 - PubMed
  70. Antimicrob Agents Chemother. 2004 Aug;48(8):3107-11 - PubMed
  71. J Clin Microbiol. 2003 Jan;41(1):78-83 - PubMed
  72. Arch Soc Esp Oftalmol. 2004 Nov;79(11):565-8 - PubMed
  73. Clin Infect Dis. 2000 Jun;30(6):981-2 - PubMed
  74. Eur J Clin Microbiol Infect Dis. 2003 May;22(5):277-83 - PubMed
  75. Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):23-30 - PubMed
  76. J Clin Oncol. 1997 Jan;15(1):139-47 - PubMed
  77. Antimicrob Agents Chemother. 2002 Sep;46(9):3039-41 - PubMed
  78. Antimicrob Agents Chemother. 2002 Jan;46(1):62-8 - PubMed
  79. Clin Infect Dis. 2005 Jan 1;40(1):89-99 - PubMed
  80. Br J Clin Pharmacol. 2003 Dec;56 Suppl 1:24-9 - PubMed
  81. J Med Microbiol. 2002 Jun;51(6):479-483 - PubMed
  82. Eur J Epidemiol. 2001;17(5):491-6 - PubMed
  83. J Antimicrob Chemother. 2000 May;45(5):673-6 - PubMed
  84. Antimicrob Agents Chemother. 2003 Jul;47(7):2342-4 - PubMed
  85. Am J Transplant. 2004 Oct;4(10):1720-4 - PubMed
  86. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1694-6 - PubMed
  87. Rev Esp Quimioter. 2003 Jun;16(2):227-32 - PubMed
  88. Korean J Ophthalmol. 2005 Mar;19(1):73-6 - PubMed
  89. Antimicrob Agents Chemother. 2003 Oct;47(10):3149-54 - PubMed
  90. Antimicrob Agents Chemother. 2004 Mar;48(3):1065 - PubMed
  91. Antimicrob Agents Chemother. 2002 Aug;46(8):2564-8 - PubMed
  92. Clin Infect Dis. 2003 Sep 1;37(5):728-32 - PubMed
  93. Antimicrob Agents Chemother. 2002 Feb;46(2):578-81 - PubMed
  94. J Antimicrob Chemother. 2005 Feb;55(2):194-9 - PubMed
  95. Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):317-22 - PubMed
  96. Med Mycol. 1998 Aug;36(4):239-42 - PubMed
  97. J Pediatr Hematol Oncol. 2003 Sep;25(9):732-4 - PubMed
  98. Transpl Infect Dis. 2004 Sep;6(3):129-31 - PubMed
  99. Pediatr Infect Dis J. 2002 Mar;21(3):240-8 - PubMed
  100. Antimicrob Agents Chemother. 1998 Nov;42(11):3018-21 - PubMed
  101. Intensive Care Med. 2002 Feb;28(2):108-21 - PubMed
  102. J Clin Microbiol. 1998 May;36(5):1436-8 - PubMed
  103. Pharmacotherapy. 2005 Jun;25(6):893-8 - PubMed
  104. Mycoses. 2003 Jun;46(5-6):233-6 - PubMed
  105. Eur J Clin Microbiol Infect Dis. 2003 Feb;22(2):111-3 - PubMed
  106. J Clin Microbiol. 2004 Oct;42(10):4577-80 - PubMed
  107. Acta Orthop Belg. 2005 Feb;71(1):119-21 - PubMed
  108. Antimicrob Agents Chemother. 2004 Nov;48(11):4441-3 - PubMed
  109. Clin Infect Dis. 2002 Mar 1;34(5):563-71 - PubMed
  110. Graefes Arch Clin Exp Ophthalmol. 2004 Oct;242(10):887-91 - PubMed
  111. Rev Esp Quimioter. 2005 Jun;18(2):149-58 - PubMed
  112. Intensive Care Med. 2004 Nov;30(11):2080-5 - PubMed
  113. Br J Ophthalmol. 2000 Aug;84(8):932-3 - PubMed
  114. Antimicrob Agents Chemother. 2001 Feb;45(2):601-4 - PubMed
  115. Am J Ophthalmol. 2005 Jan;139(1):135-40 - PubMed
  116. Clin Infect Dis. 2003 Mar 1;36(5):630-7 - PubMed
  117. Rev Iberoam Micol. 2005 Mar;22(1):24-8 - PubMed
  118. Support Care Cancer. 2003 Nov;11(11):722-7 - PubMed
  119. Blood. 2005 Oct 15;106(8):2641-5 - PubMed
  120. Med Pediatr Oncol. 2003 Nov;41(5):494-5 - PubMed
  121. Clin Microbiol Infect. 2004 Oct;10(10):925-8 - PubMed
  122. Eur J Clin Microbiol Infect Dis. 2004 Nov;23(11):836-40 - PubMed
  123. J Chemother. 1999 Feb;11(1):34-9 - PubMed
  124. J Clin Microbiol. 1999 May;37(5):1606-9 - PubMed
  125. Clin Infect Dis. 1998 Dec;27(6):1437-41 - PubMed
  126. Pediatr Infect Dis J. 2003 Dec;22(12):1109-10 - PubMed
  127. Clin Microbiol Infect. 2003 Jul;9(7):750-3 - PubMed
  128. Clin Infect Dis. 2003 Jun 15;36(12):1619-22 - PubMed
  129. Antimicrob Agents Chemother. 2002 Sep;46(9):3091-3 - PubMed
  130. N Engl J Med. 2004 Feb 26;350(9):950-2 - PubMed
  131. Eur J Clin Microbiol Infect Dis. 2003 Jul;22(7):408-13 - PubMed
  132. Clin Infect Dis. 2005 Sep 1;41(5):752-3 - PubMed
  133. Lancet. 2005 Oct 22-28;366(9495):1435-42 - PubMed
  134. J Clin Microbiol. 2004 Dec;42(12):5846-8 - PubMed
  135. J Heart Lung Transplant. 2004 May;23(5):647-9 - PubMed
  136. Antimicrob Agents Chemother. 1997 Jul;41(7):1612-4 - PubMed
  137. Antimicrob Agents Chemother. 2002 Apr;46(4):1144-6 - PubMed
  138. Diagn Microbiol Infect Dis. 1999 Sep;35(1):19-25 - PubMed
  139. Clin Infect Dis. 2004 Sep 1;39(5):743-6 - PubMed
  140. Ann Pharmacother. 2004 Mar;38(3):414-7 - PubMed
  141. Scand J Infect Dis. 2004;36(4):312-4 - PubMed
  142. Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):651-5 - PubMed
  143. Clin Infect Dis. 1997 Jul;25(1):158-60 - PubMed
  144. Antimicrob Agents Chemother. 2004 Oct;48(10):4009-11 - PubMed
  145. Bone Marrow Transplant. 2002 Dec;30(12):967-70 - PubMed
  146. Ann Pharmacother. 2003 Mar;37(3):420-32 - PubMed
  147. J Clin Microbiol. 2004 Oct;42(10):4907-8 - PubMed
  148. Mycopathologia. 2001;150(3):101-15 - PubMed
  149. Antimicrob Agents Chemother. 2000 Oct;44(10):2865-8 - PubMed
  150. Drugs. 2004;64(18):1997-2020 - PubMed
  151. Eur J Clin Microbiol Infect Dis. 2004 Aug;23(8):619-24 - PubMed
  152. Cancer Control. 2003 Sep-Oct;10(5):414-9 - PubMed
  153. Med Mycol. 2003 Aug;41(4):339-45 - PubMed
  154. Bone Marrow Transplant. 2004 Nov;34(9):815-7 - PubMed
  155. Pediatr Infect Dis J. 2004 Jun;23(6):584-6 - PubMed
  156. J Infect Dis. 2005 Apr 15;191(8):1350-60 - PubMed
  157. J Clin Microbiol. 2005 Jan;43(1):476-8 - PubMed
  158. J Antimicrob Chemother. 2005 Feb;55(2):188-93 - PubMed
  159. Antimicrob Agents Chemother. 1997 Apr;41(4):841-3 - PubMed
  160. Clin Microbiol Infect. 2004 Oct;10(10):928-31 - PubMed
  161. Transplant Proc. 2004 Dec;36(10):3226-8 - PubMed
  162. Pharmacotherapy. 2004 Aug;24(8):1084-8 - PubMed
  163. Antimicrob Agents Chemother. 1996 Jan;40(1):86-91 - PubMed
  164. J Clin Microbiol. 2005 Oct;43(10):5208-13 - PubMed
  165. Antimicrob Agents Chemother. 2004 Jun;48(6):2014-20 - PubMed
  166. J Clin Microbiol. 2004 Oct;42(10):4419-31 - PubMed
  167. Eur J Clin Microbiol Infect Dis. 2004 Jun;23(6):506-8 - PubMed
  168. Drugs. 2002;62(18):2655-64; discussion 2665-6 - PubMed
  169. J Clin Microbiol. 1999 Mar;37(3):870-2 - PubMed
  170. Clin Infect Dis. 2005 Feb 15;40(4):e35-7 - PubMed
  171. J Clin Microbiol. 1998 Jan;36(1):198-202 - PubMed
  172. Bone Marrow Transplant. 2003 Mar;31(5):411-2 - PubMed
  173. Chemotherapy. 2000 Nov-Dec;46(6):395-401 - PubMed
  174. Enferm Infecc Microbiol Clin. 2003 Nov;21(9):484-7 - PubMed
  175. Antimicrob Agents Chemother. 2005 Oct;49(10):4026-34 - PubMed
  176. J Clin Microbiol. 2005 Feb;43(2):973-7 - PubMed
  177. Retina. 2004 Apr;24(2):319-20 - PubMed
  178. J Clin Microbiol. 2003 Aug;41(8):3623-6 - PubMed
  179. Mycoses. 2002 Nov;45(9-10):418-27 - PubMed
  180. J Antimicrob Chemother. 2004 May;53(5):739-42 - PubMed
  181. Drugs Today (Barc). 2001 Feb;37(2):135-148 - PubMed
  182. J Clin Microbiol. 2003 Oct;41(10):4898-900 - PubMed
  183. Clin Ther. 2003 May;25(5):1321-81 - PubMed
  184. Clin Infect Dis. 2004 Sep 15;39(6):797-802 - PubMed
  185. J Cyst Fibros. 2005 Dec;4(4):215-20 - PubMed
  186. South Med J. 2004 Jul;97(7):683-7 - PubMed
  187. Mycoses. 2003 Dec;46(11-12):511-4 - PubMed
  188. Br J Dermatol. 2004 Apr;150(4):777-8 - PubMed
  189. Pediatr Clin North Am. 2005 Jun;52(3):895-915, viii - PubMed
  190. Clin Infect Dis. 2000 Dec;31(6):1499-501 - PubMed
  191. Mycoses. 2002 Dec;45(11-12):504-11 - PubMed
  192. J Clin Microbiol. 2002 Sep;40(9):3204-8 - PubMed
  193. J Clin Microbiol. 2003 Aug;41(8):3981-5 - PubMed
  194. J Antimicrob Chemother. 1998 Oct;42(4):531-3 - PubMed
  195. Pediatr Infect Dis J. 2004 Nov;23(11):1059-61 - PubMed
  196. Leuk Lymphoma. 2004 Oct;45(10):2161-3 - PubMed
  197. J Clin Microbiol. 2003 May;41(5):2261-4 - PubMed
  198. Fed Regist. 1999 May 28;64(103):29046-7 - PubMed
  199. Clin Infect Dis. 2001 Nov 1;33(9):1447-54 - PubMed
  200. Medicine (Baltimore). 2002 Sep;81(5):333-48 - PubMed
  201. Infection. 2003 Aug;31(4):241-3 - PubMed
  202. Br J Haematol. 2004 Jul;126(2):165-75 - PubMed
  203. Mycoses. 2004 Jun;47(5-6):177-83 - PubMed
  204. Diagn Microbiol Infect Dis. 2003 Aug;46(4):259-64 - PubMed
  205. Mayo Clin Proc. 2004 May;79(5):707-8 - PubMed
  206. Clin Infect Dis. 2005 Mar 1;40(5):770-1 - PubMed
  207. J Clin Microbiol. 2004 Oct;42(10):4805-8 - PubMed
  208. Clin Infect Dis. 2003 May 1;36(9):1122-31 - PubMed
  209. J Pediatr Hematol Oncol. 2004 May;26(5):304-7 - PubMed
  210. Clin Infect Dis. 2002 Oct 1;35(7):e78-81 - PubMed
  211. Neurosurg Focus. 2004 Dec 15;17(6):E9 - PubMed
  212. J Clin Microbiol. 2005 Aug;43(8):3884-9 - PubMed
  213. Hematol J. 2004;5(2):178-80 - PubMed
  214. Antimicrob Agents Chemother. 2005 Feb;49(2):512-7 - PubMed
  215. J Clin Microbiol. 2005 May;43(5):2163-7 - PubMed
  216. Antimicrob Agents Chemother. 2002 Jun;46(6):1723-7 - PubMed

Publication Types